Inferences & Models in Science, Logic, Language, and Technology
Chairs: Emiliano Ippoliti, Lorenzo Magnani, Selene Arfini
June 7-9 2023 – Rome, Italy
Department of Philosophy, Sapienza University of Rome
Villa Mirafiori – Via Carlo Fea 2, 00161 Roma
Rooms: II, VI, X
(Seventh International MBR Conference)
The PhilInBioMed network, the University of Bordeaux, the CNRS and Bordeaux Summer Schools, are pleased to announcethe launch of the 2023 edition of the Philosophy in Biology and Medicine Summer School (https://bss-philinbiomed.u-bordeaux.fr/en/).
Taking place in the historic city center of Bordeaux, France,from June 12th to June 16th, 2023,it welcomes Master students, PhD students, and postdocs, from the fieldsof philosophy, life sciences, and medicine.Participants will learn to use interdisciplinary methods to address conceptual issues in scientificresearch. The Summer School starts with a lecture by Elliott Sober (University of Wisconsin), laureate of the 2023 PhilInBioMedAward. Discussants are Kevin Lala (formerly Laland), Ford Doolittle, and Silvia De Monte.
Courseleaders will be present throughout the week providing examples of interdisciplinary research based on their own experience, as well as interacting and advising participants ontheir projects. Course leaders includeSilvia De Monte(Evolutionary Biology, ENS Paris),Andy Ewald (Medicine, Johns Hopkins), Lucie Laplane(Philosophy, IHPST Paris & Gustave Roussy), and Lauren Ross(Philosophy, UC Irvine), alongwith localorganizers.
The deadline for registration is March 31st, 2023.The fees are €500 for Master students and PhD students and €700 for postdocs (including lunch, coffee breaks and accommodation).
A limited number of grants will be available upon demand.
The global interventional cardiology market was estimated to be worth $11.1 billion in 2020. Due to the impact of COVID-19, in Cardiology 2023, down from nearly $14 billion in 2019. The global market is expected to reach $16.2 billion by 2027, and the cardiovascular devices market was worth more than USD 47,105 million in 2016, with a CAGR of 6.7 percent predicted from 2021 to 2026.
More than 40% of the global interventional cardiology market was controlled by Boston Scientific, Abbott, and Medtronic. This global market research includes a look at 46 interventional cardiology firms operating ins over 70 countries around the world.
